United States · FDA National Drug Code directory
Nerlynx
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70437-240_55a7b5be-747b-8497-e063-6294a90a8923
- Product NDC
- 70437-240
- Form
- TABLET
- Composition / generic term
- neratinib
- Labeler
- Puma Biotechnology, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170717
- Source listing expiry
- 20271231
Source-listed ingredients
- NERATINIB MALEATE ANHYDROUS — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 BOX (70437-240-18) / 180 TABLET in 1 BOTTLE · 70437-240-18
- 1 BOTTLE in 1 BOX (70437-240-26) / 126 TABLET in 1 BOTTLE · 70437-240-26
- 1 BOTTLE in 1 BOX (70437-240-33) / 133 TABLET in 1 BOTTLE · 70437-240-33
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →